People: Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.54USD
26 Dec 2014
Price Change (% chg)

$-0.02 (-2.93%)
Prev Close
$0.56
Open
$0.57
Day's High
$0.57
Day's Low
$0.54
Volume
13,300
Avg. Vol
44,930
52-wk High
$1.56
52-wk Low
$0.36

Search Stocks

Harland, Henri 

Brief Biography

Mr. Henri Harland serves as Director of Acasti Pharma Ltd. He resigned as President, Chief Executive Officer of the Company effective April 28, 2014. Mr. Harland is an Actuary and holds a MBA (Finance) from Laval University. Mr. Henri Harland has been a director as well as the President and Chief Executive Officer of Neptune since its incorporation on October 9, 1998. He is the founder of the Corporation and of Neptune and has been involved in the krill research project since 1991. For more than ten years he has held the position of President and Chief Executive Officer of Gestion Harland Inc., a financial engineering group. Previously, he acted as an independent financial consultant for companies in different industrial sectors in both North America and Europe guiding them through recapitalization, financing and business development.

Basic Compensation

Total Annual Compensation, CAD Long-Term Incentive Plans, CAD All Other, CAD Fiscal Year Total, CAD
128,712 -- 119,487 740,379

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jerald Wenker

--

Andre Godin

89,100

Pierre Lemieux

479,813

Harlan Waksal

1,219,480

Tina Sampalis

101,975

Ronald Denis

--
As Of 27 Feb 2014
Search Stocks